Activity of the human metallothionein promoter (hMT-IIA) in cell populations isolated from varying depths in multicell spheroids following exposure to cadmium.
In order to evaluate whether tumor microenvironment might influence the response of the metallothionein promoter to heavy-metal exposure, we transfected HT-29 colon carcinoma cells with the vector phMTIIA-CAT-neo, containing a fusion gene consisting of 426 bp of the human metallothionein-IIa (hMT-IIA) promoter immediately upstream of the bacterial chloramphenicol acetyl transferase (CAT) gene. We grew one of the stable transfectants (clone 20) as three-dimensional multicell tumor spheroids, exposed them to CdCl2 and measured CAT expression in cells isolated from various depths into the spheroids. Cellular populations were isolated by flow cytometry on the basis of Hoescht 33342 fluorescence intensity, taking advantage of the dye's diffusion gradient to isolate cells from inner (dim) and outer (bright) regions of stained spheroids. When intact spheroids were incubated for 18 h in the presence of 5 microM CdCl2, CAT activity was induced in all cell fractions isolated from the spheroids, but induction was 10-fold greater in cells in the outermost fraction (fraction 10) than inner fraction (fraction 2). When spheroids were dissociated, sorted into individual fractions and then incubated with cadmium, CAT expression was maximized in all fractions. Exposure of intact spheroids to 30 microM CdCl2 resulted in increased CAT induction in cells isolated from the internal fractions of the spheroids. The data suggest that limited diffusion of cadmium through cells organized in a tissue-like arrangement may account for the lower levels of hMT-IIA promoter activity observed in cells collected from increasing depths into the spheroids.
Untawale
S
S
Department of Human Oncology, University of Wisconsin-Madison 53792.
Mulcahy
R T
RT
D002104:Cadmium / Q000494:pharmacology*; D015500:Chloramphenicol O-Acetyltransferase / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000503:physiopathology; D066298:In Vitro Techniques; D008668:Metallothionein / Q000235:genetics*; D009940:Organoids; D011401:Promoter Regions, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000166:cytology* / Q000502:physiology
D002104:Cadmium; D008668:Metallothionein; D015500:Chloramphenicol O-Acetyltransferase